Top Story

BRAF mutation linked to recurrence in differentiated thyroid cancer

October 31, 2014

CORONADO, Calif. — The incidence of the BRAF V600E mutation, in the absence of other somatic mutations, was significantly associated with locoregional recurrence among patients with differentiated thyroid cancers, according to study results presented at the American Thyroid Association Annual Meeting.

In addition, telomerase reverse-transcriptase (TERT) promoter mutations were frequently detected in advanced differentiated thyroid cancers, especially in disease associated with distant metastasis.

figure Meeting News Coverage

Differentiated thyroid carcinoma benefitted from total/near-total thyroidectomy followed by RAI

October 31, 2014
CORONADO, Calif. — A survival benefit was found among patients with differentiated thyroid carcinoma who underwent total/near-total thyroidectomy followed by…
In the Journals

Treatment, biliary drainage improved survival in HCC, obstructive jaundice

October 31, 2014
Chemotherapy, transarterial chemoembolization and successful biliary drainage were effective in improving overall survival among patients with unresectable…
figure Meeting News Coverage

Increased imaging improved early detection in well-differentiated thyroid cancer

October 31, 2014
CORONADO, Calif. — Patients diagnosed with well-differentiated thyroid cancer after 2000 were more likely to exhibit lower risk disease, according to study results…
More News Headlines »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Video
figure

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »